Results 191 to 200 of about 54,096 (328)

Efficacy and Safety of Combining r‐ATG With PTCy for GvHD Prophylaxis in Haploidentical HSC Transplantation for Malignancies—A Systematic Review

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 11, June 2025.
ABSTRACT Allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancies can cause acute and chronic graft‐versus‐host disease (GvHD), impacting graft success and mortality. Rabbit anti‐thymocyte globulin (r‐ATG) or post‐transplant cyclophosphamide (PTCy) is effective in reducing GvHD in haploidentical‐HSCT.
Joseph M. John   +3 more
wiley   +1 more source

Urinary hydroxyproline excretion in myelofibrosis [PDF]

open access: bronze, 1980
JC Wang, MK Aung, MS Tobin
openalex   +1 more source

MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? [PDF]

open access: yes, 2019
Accurso, V.   +8 more
core   +1 more source

Novel approaches in myelofibrosis

open access: yesHemaSphere
AbstractMyelofibrosis (MF) is a clonal myeloid neoplasm characterized by bone marrow fibrosis, splenomegaly, and disease‐associated symptoms, as well as increased mortality, due to thrombosis, severe bleeding, infections, or progression to acute leukemia.
openaire   +3 more sources

Non‐Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1‐Negative Myeloproliferative Neoplasms

open access: yesLiver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background & Aims The course of BCR::ABL1‐negative myeloproliferative neoplasms (MPN) is frequently complicated by thromboembolic events in the splanchnic venous system, resulting in portal hypertension (PH). Therefore, the introduction of spleen stiffness measurement (SSM) might improve the diagnosis of PH.
Lorenz Balcar   +17 more
wiley   +1 more source

Myelofibrosis and T3-thyreotoxicosis in a girl with McCune-Albright Syndrome [PDF]

open access: bronze, 1981
Birgit Peitersen   +3 more
openalex   +1 more source

Profile of pomalidomide and its potential in the treatment of myelofibrosis

open access: yesTherapeutics and Clinical Risk Management, 2015
Krisstina L Gowin, Ruben A Mesa Division of Hematology and Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA Abstract: Myelofibrosis, a Philadelphia-negative myeloproliferative neoplasm, is in a new treatment era after the discovery of ...
Gowin KL, Mesa RA
doaj  

Home - About - Disclaimer - Privacy